Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the gmp cell therapy consumables market size evolved in recent years?

The market size for GMP cell therapy consumables has seen a significant increase lately. It is predicted to rise from $17.85 billion in 2024 to $22.87 billion in 2025, indicating a compound annual growth rate (CAGR) of 28.1%. The prior growth in this market can be linked to factors such as the increase in investments towards regenerative medicine, progress in cell therapy research, approval and execution of clinical trials, the escalating presence of chronic diseases, and an enhanced understanding of personalized medicine.

What are the predictions for the gmp cell therapy consumables market size in the coming years?

Anticipations are high for a significant expansion in the GMP cell therapy consumables market in the forthcoming years. The market is predicted to amplify to $59 billion by 2029, progressing at a compound annual growth rate (CAGR) of 26.7%. The anticipated growth within the forecast period can be linked to the broadening of cell therapy applications, increase in global cell therapy trials, bolstered regulatory support for cell therapies, the advent of advanced cell therapy platforms and the spread of cell therapy manufacturing on a global scale. The future trends to keep an eye on include an increase in investments toward manufacturing infrastructure, technological advancements in cell processing, burgeoning partnerships and collaborations, digital transformation and data integration, and strategic alliances and mergers.

Get your gmp cell therapy consumables market report here!

https://www.thebusinessresearchcompany.com/report/gmp-cell-therapy-consumables-global-market-report

What key factors are fueling the growth of the gmp cell therapy consumables market?

Predictions suggest that the GMP cell therapy consumables market will continue to expand due to the increase in drug discovery. Drug discovery encompasses the identification of new potential medicinal elements, utilizing computational, experimental, translational, and clinical models. The progress in molecular biology, genetics, bioinformatics, and high-throughput screening techniques has facilitated a shift in drug discovery approaches. Such technologies give researchers a deeper understanding of disease mechanisms, enabling them to discover viable drug targets and filter through extensive compound libraries for drug candidates in an efficient manner. This upward trend in drug discovery is bolstering the growth of the GMP cell therapy consumables market. For example, the US-based Food and Drug Administration, a federal agency of the Department of Health and human services, reported in January 2023 that 37 new drugs and therapeutic biological products received approval from FDA’s Centre for Drug Evaluation and Research (CDER) in 2022 for a range of indications. Consequently, this swell in drug discovery is fueling the growth of the GMP cell therapy consumables market.

How is the global gmp cell therapy consumables market divided into key segments?

The GMP cell therapy consumables market covered in this report is segmented –

1) By Product: Kits, Reagents Or Molecular Biology reagents, Growth Factors Or Cytokines And Interleukins, Other Products

2) By Cell Therapy: NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, Other cell therapies

3) By Process: Cell Collection And Characterization Or Sorting And Separation, Cell Culture And Expansion Or Preparation, Cryopreservation, Cell Processing And Formulation, Cell Isolation And Activation, Cell Distribution Or Handling, Process Monitoring And Control Or Readministration Or Quality Assurance, Other Processes

4) By End-Use: Clinical, Commercial, Research

Subsegments:

1) By Kits: Cell Culture Kits, Cell Isolation Kits, Transfection Kits

2) By Reagents Or Molecular Biology Reagents: Buffers And Solutions, Enzymes, Staining Reagents

3) By Growth Factors Or Cytokines And Interleukins: Hematopoietic Growth Factors, Antibody Cytokines, Immunomodulatory Cytokines

3) By Other Products: Cell Culture Vessels, Bioreactors, Media And Supplements

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12014&type=smp

Who are the key firms paving the way for growth in the gmp cell therapy consumables market?

Major companies operating in the GMP cell therapy consumables market include Thermo Fisher Scientific Inc., Fresenius Kabi AG, Danaher Corporation, Merck KGaA, Asahi Kasei Corporation, GE HealthCare Technologies Inc., Corning Incorporated, Avantor Inc., Lonza Group AG, Terumo Corporation, Catalent Inc., Sartorius AG, Bio-Techne Corp, Repligen Corporation, Miltenyi Biotec BV & Co KG, Genscript Biotech Corporation, Rentschler Biopharma SE, FUJIFILM Irvine Scientific Inc., BioLegend Inc., STEMCELL Technologies Inc., BioLife Solutions Inc., Abzena Ltd., Sino Biological Inc., ProBioGen AG, MaxCyte Inc., PromoCell GmbH, PeproTech Inc., Cellares Corp., Wilson Wolf Corporation, Cellexus Ltd.

Which trends are expected to transform the gmp cell therapy consumables market?

Leading entities in the GMP cell therapy consumables market are focusing on the creation of GMP-compliant CD34+ hematopoietic stem cells (HSCs) to aid advanced treatments. These GMP-compliant CD34+ hematopoietic stem cells (HSCs) are a unique type of stem cell that display the CD34 marker on their outer layer and are manufactured under the Good Manufacturing Practice (GMP) protocol. For instance, in April 2024, a pharmaceutical corporation based in the United States, OrganaBio, introduced HematoPAC-HSC-CB-GMP, an accessible source of GMP-compliant CD34+ hematopoietic stem cells (HSCs) sourced directly from fresh human umbilical cord blood. OrganaBio leverages its profound grounding in cellular separation and GMP production to generate highly viable CD34+ HSCs within a day of collection. The goal of this launch is to pave the way for the creation of future therapies, especially those targeting blood cancers and genetic diseases.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12014

What regions are contributing significantly to the growth of the gmp cell therapy consumables market?

North America was the largest region in the GMP cell therapy consumables market in 2024. Asia-pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the GMP cell therapy consumables market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Powder Coatings Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/powder-coatings-global-market-report

Water Borne Coatings Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/water-borne-coatings-global-market-report

Conformal Coatings Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/conformal-coatings-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: